Bedel Financial Consulting, Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bedel Financial Consulting, Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$4,000
-20.0%
7300.0%0.00%
-50.0%
Q4 2021$5,000
-28.6%
7300.0%0.00%0.0%
Q3 2021$7,000
-22.2%
7300.0%0.00%
-33.3%
Q2 2021$9,0000.0%7300.0%0.00%0.0%
Q1 2021$9,000
-18.2%
7300.0%0.00%
-40.0%
Q4 2020$11,000
+83.3%
730
+12.3%
0.01%
+66.7%
Q3 2020$6,0000.0%6500.0%0.00%0.0%
Q2 2020$6,000
-91.2%
650
-93.9%
0.00%
-93.3%
Q1 2020$68,000
+1260.0%
10,650
+1538.5%
0.04%
+1400.0%
Q4 2019$5,000
-16.7%
6500.0%0.00%
-25.0%
Q3 2019$6,000
-14.3%
6500.0%0.00%0.0%
Q2 2019$7,000
+16.7%
6500.0%0.00%0.0%
Q1 2019$6,000
-14.3%
6500.0%0.00%
-20.0%
Q4 2018$7,000
-22.2%
6500.0%0.01%
-16.7%
Q3 2018$9,0000.0%6500.0%0.01%
-14.3%
Q2 2018$9,000
-25.0%
6500.0%0.01%
-22.2%
Q1 2018$12,0006500.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders